Direkt zum Inhalt
Merck
  • Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis.

Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis.

Heart failure reviews (2012-06-05)
Massimo Imazio, Yehuda Adler
ZUSAMMENFASSUNG

Empiric anti-inflammatory therapy for acute and recurrent pericarditis is warranted for viral and idiopathic cases that represent most cases of pericarditis in developed countries. For specific uncomplicated etiologies, such as systemic autoimmune diseases and postpericardiotomy syndromes, the same drugs are also indicated. Aspirin and non-steroidal anti-inflammatory drugs (NSAID) are mainstay of therapy with the possible adjunct of colchicine, especially for recurrences. Corticosteroids are a second choice for difficult cases requiring multi-drug therapies and specific medical conditions (i.e., specific cases with systemic autoimmune diseases, postpericardiotomy syndrome, and pregnancy). Medical therapy of pericarditis should be individualized as much as possible providing the attack dose every 8 h to ensure full daily control of symptoms and till remission and C-reactive protein normalization, and then tapering should be considered. The present paper will review current evidence for the treatment of acute and recurrent pericarditis with aspirin, NSAID, corticosteroids, and colchicine.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Colchicin, ≥95% (HPLC), powder
Sigma-Aldrich
Colchicin, BioReagent, suitable for plant cell culture, ≥95% (HPLC)
Colchicin, (European Pharmacopoeia (EP) Reference Standard)